CDKN2 Mutation Is Infrequent in German Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|57|4|306-310

ISSN： 0030-2414

Source： Oncology, Vol.57, Iss.4, 1999-11, pp. : 306-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Loss of p16/CDKN2A Protein in Epstein-Barr Virus-Associated Gastric Carcinoma

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 81-87

Karger

Access to resources Recommend Favorite

ANGPTL2 promotes liver cancer metastasis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 396-404

John Wiley & Sons Inc

Access to resources Recommend Favorite

TPX2 as a novel prognostic biomarker for hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 8, 2015-08 ,pp. : 906-918

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta‐regression analysis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 977-983

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells

By        

International Journal of Molecular Medicine, Vol. 34, Iss. 3, 2014-01 ,pp. : 842-848

Spandidos Publications

Access to resources Recommend Favorite